THE PICOLAZER

The first affordable, dual wavelength (1064nm and 532nm) pico-second laser for comfortable and convenient tattoo removal and skin revitalization treatments for wrinkles, acne scars and pigment like freckles, sunspots and discoloration.

$60.000   

Contact us for details
pico-laser

TATTOO STATISTICS

  • 36% of Americans between the age of 18 and 29 have at least one tattoo.
  • 21% (45 million) of all Americans have at least one tattoo.
  • 72% of adults with tattoos have ones that are hidden by their clothing.
  • 17% (7.6 million) of adults with tattoos hide them with clothing because they regret having them.
Watch Video Testimonials

THE PICOLAZER BENEFITS

INCREDIBLE RESULTS

Slide the arrows left and right to compare the before and after images.

HEAR WHAT OUR CLIENTS HAVE TO SAY

“I have purchased the Phoenix-15 and have nothing but praise for the device. When one looks at the cost, lack of consumables, the ability to treat hands, along with the reliability and dependability of all of Mark Rohrer’s products it was an easy choice to make. I highly recommend this device for anyone entering into the arena of fractionated CO2 laser skin resurfacing.”

John H. Joseph, MD

“I have now purchased 5 lasers from Rohrer Aesthetics. The first purchase was in 2004 and that laser is still going strong with excellent results and no service calls to date. My recent choice of lasers was the Phoenix CO2 and Spectrum multiwavelength platform. This company is leading the way in providing a single platform that can legitimately treat a multitude of problems and areas. These lasers are truly the “swiss army knives” of light based therapy”

Lionel D Meadows, MD, FACOG

“I find the Rohrer Aesthetics sales team to be dependable and trustworthy. Professional service is always a phone call away. (Fortunately, this has been an uncommon need over the years). My clinical results are excellent and well within the acceptable standards. Overall, I wholeheartedly recommend a good look at the product line.”

Fred Fedok, MD, FACS